NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL

by A. S. Galjavich, S. N. Merjasev, R. A. Galjavi, R. F. Merjaseva
Published 2016-01-01

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL

by A. S. Galjavich, S. N. Merjasev, R. A. Galjavi, R. F. Merjaseva
Published 2016-01-01

The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochloroth...

by I E Chazova, T V Martynyuk, R Accetto, Yu Sirenko, J Vincelj, Jr JWidimsky, B Barbič-Žagar, M V Arhipov, Yu I Grinshtein, O D Ostroumova, A S Galjavich, O P Rotar', L A Haisheva, S V Nedogoda
Published 2017-06-01

The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arte...

by I E Chazova, T V Martynyuk, R Accetto, Yu N Sirenko, J Vincelj, Jr Widimsky, B Barbič-Žagar, M V Arhipov, Yu I Grinshtein, O D Ostroumova, A S Galjavich, O P Rotar, L A Haisheva, S V Nedogoda
Published 2018-06-01